[1] Ferlay J,Shin HR,Bray F,et al. GLOBOCAN 2008,Cancer incidence and mortality worldwide: IARC Cancer Base No.10.2010[2013-03-01].http://globocan.iarc.fr.
[2] Miller DL,Puricelli MD,Stack MS. Virology and molecular pathogenesis of HPV(human papillomavirus)-associated oropharyngeal squamous cell carcinoma. Biochem J,2012,443:339-353.
[3] Rautava J,Syrjnen S.Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol,2012,6 Suppl 1:S3-15.
[4] Ghittoni R,Accardi R,Hasan U,et al. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes,2010,40:1-13.
[5] Hamid NA,Brown C,Gaston K. The regulation of cell proliferation by the papillomavirus early proteins. Cell Mol Life Sci,2009,66:1700-1717.
[6] Moody CA,Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer,2010,10:550-560.
[7] Münger K,Baldwin A,Edwards KM,et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol,2004,78:11451-11460.
[8] Javier RT,Rice AP. Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol,2011,85:11544-11556.
[9] 王卓颖,田敖龙,王弘士,等.头颈部鳞状细胞癌组织中人乳头状瘤病毒的检测及其意义.中华实验和临床病毒学杂志,2003,17:200.
[10] American Cancer Society. Cancer Facts and Figures 2010.Atlanta: American Cancer Society,2010.
[11] SEER Cancer Statistics Review,1975-2006[2013-03-01].http://seer.cancer.gov/csr/1975_2003/.
[12] Tran N,Rose BR,O′Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck,2007,29:64-70.
[13] Ragin CC,Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer,2007,121:1813-1820.
[14] Applebaum KM,Furniss CS,Zeka A,et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst,2007,99:1801-1810.
[15] Ribeiro KB,Levi JE,Pawlita M,et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.Int J Epidemiol,2011,40:489-502.
[16] Snijder PJF,Scholes AGM,Hart CA,et al. Prevalence of mucosatropic human papillomaviruses in squamous cell carcinomas of the head and neck. Int J Cancer,1996,66:464-469.
[17] Descamps G,Duray A,Rodriguez A,et al. Detection and quantification of human papillomavirus in benign and malignant parotid lesions. Anticancer Res,2012,32:3929-3932.
[18] Wei W,Shi Q,Guo F,et al. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncol Rep,2012,28:1750-1756.
[19] 黄辉,张彬,陈汶,等.口咽部鳞状细胞癌人乳头状瘤病毒感染预后初步分析.中华耳鼻咽喉头颈外科杂志,2012,47:207-211.
[20] Laantri N,Attaleb M,Kandil M,et al. Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer,2011,6:3-8.
[21] Lohavanichbutr P,Houck J,Fan W,et al. Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Arch Otolaryngol Head Neck Surg,2009,135:180-188.
[22] Martinez I,Wang J,Hobson KF,et al. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer,2007,43:415-432.
[23] Chaturvedi AK,Engels EA,Anderson WF,et al. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol,2008,26:612-619.
[24] Ang KK,Harris J,Wheeler R,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med,2010,363:24-35.
[25] Gillison M. HPV and its effect on head and neck cancer prognosis. Clin Adv Hematol Oncol,2010,8:680-682.
[26] Fakhry C,Westra WH,Li S,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst,2008,100:261-269.
[27] Paz IB,Cook N,Odom-Maryon T,et al. Human papillomavirus(HPV) in head and neck cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer′s tonsillar ring. Cancer,1997,79:595-604.
[28] Ryerson AB,Peters ES,Coughlin SS,et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US,1998-2003. Cancer,2008,113:2901-2909.
[29] Charfi L,Jouffroy T,de Cremoux P,et al. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology,molecular features and outcome. Cancer Lett,2008,260:72-78.
[30] Pannone G,Santoro A,Papagerakis S,et al. The role of human papillomavirus in the pathogenesis of head and neck squamous cell carcinoma: an overview. Infect Agent Cancer,2011,6:4-14.
[31] Licitra L,Perrone F,Bossi P,et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol,2006,24:5630-5636.
[32] Lindquist D,Romanitan M,Hammarstedt L,et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.Mol Oncol,2007,1:350-355.
[33] Lassen P,Eriksen JG,Hamilton-Dutoit S,et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol,2009,27:1992-1998.
[34] Settle K,Posner MR,Schumaker LM,et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res,2009,2:776-781.
[35] Fakhry C,Westra WH,Li S,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst,2008,100:261-269.
[36] Ciuliano AR,Anic C,Alan C,el al. Nyitray,epidemiology and pathology of HPV disease in males. Cynecol Oncol,2010,117:15-19. |
|
|
2013, Vol. 22 
